Australasian Business Intelligence - Arthritis drug in heart risk alert.
Byline: Adam Cresswell
Most Popular
10 Jobs That Pay $30 An Hour
Public Speaking: 7 Secrets Of Great Public Speakers
Not business as usual: Changing channels in consumer electronics
3 Questions No Job Seeker Ever Wants To Be Asked?
Job Interviewing: How To Sell Yourself Like A Product
Sep 13, 2006 (The Australian - ABIX via COMTEX) — Two drugs used to relieve arthritis symptoms in Australia have been linked to a slightly increased risk of heart attack and stroke. Diclofenac is widely available over the counter under the popular Voltaren brand name, while meloxicam is sold as Mobic and Movalis and experienced a boost in sales following the 2004 ban on rival Vioxx. The Australian Medical Association and National Prescribing Service have both conceded there are risks involved in the use of diclofenac and meloxicam, but argue that if …
Read the rest of this article with a Free Trial at HighBeam Research.
